Skip to main content
. 2020 Mar 10;2020:7196189. doi: 10.1155/2020/7196189

Table 5.

Biochemical (PSA) failure, metastatic disease, prostate cancer death, and overall survival by risk groups.

Risk group (number) Biochemical failure (%) Metastatic disease (%) Died of prostate cancer (%) Died (%)
Low (373) 87 (23%) 12 (3%) 15 (4%) 280 (75%)
IM (112) 56 (50%) 6 (5%) 8 (7%) 91 (81%)
High (96) 69 (72%) 18 (19%) 21 (22%) 87 (91%)
Total (581) 212 (36%) 36 (6%) 44 (8%) 458 (79%)

IM = intermediate.